Palatin Technologies, Inc. was founded in November 1986 by Robert S. Baltera, M.D. and Edward Kuchinsky. In 1989, the company's first patent was issued for the work of its founders on the development of therapeutic applications of PYY and Leptin modulators. The 1990s saw the establishment of collaborations and partnerships with the many of the world's leading pharmaceutical companies and the initiation of Palatin’s clinical program of proprietary drug development.
